State of the art coronary heart disease risk estimations based on the Framingham heart study

Central European Journal of Public Health

Volumn 13, Issue 4, 2005, Pages 180-186

  Reissigova J ^a,b   Tomeckova M ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b INSTITUTE OF COMPUTER SCIENCE   (Czech Republic)

Author keywords

Calibration; Coronary heart disease; Discrimination; Framingham heart study; Risk; Validation study

Indexed keywords

ACCURACY; ARTICLE; CALIBRATION; DATA ANALYSIS; DATA EXTRACTION; HUMAN; ISCHEMIC HEART DISEASE; MEDICAL LITERATURE; MEDICAL RESEARCH; PATIENT CODING; PUBLICATION; RISK ASSESSMENT; RISK FACTOR; SYSTEMATIC REVIEW; VALIDATION PROCESS;

ADULT; AGED; CLINICAL TRIALS; CORONARY DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; WORLD HEALTH;

EID: 30744467424     PISSN: 12107778     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Rayner M, Petersen S; British Heart Foundation. European cardiovascular disease statistics. London: British Heart Foundation; 2000.
2. Deaths 2003. Prague, Institute of Health Information and Statistics of the Czech Republic, 2004. (In Czech)
3. Grundy SM, Pasternak R, Greenland P, Smith S Jr, Fuster V. Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Circulation. 1999 Sep 28;100(13):1481-92.
4. De Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R, Dallongeville J, Ebrahim S, Faergeman O, Graham I, Mancia G, Manger Cats V, Orth-Gomer K, Perk J, Pyorala K, Rodicio JL, Sans S, Sansoy V, Sechtem U, Silber S, Thomsen T, Wood D; Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J. 2003 Sep;24(17):1601-10.
5. Anderson KM, Wilson PW, Odell PM, Kannel WB. An updated coronary risk profile. A statement for health professionals. Circulation. 1991 Jan;83(1):356-62.
6. Anderson KM, Odell PM, Wilson PW, Kannel WB. Cardiovascular disease risk profiles. Am Heart J. 1991 Jan;121(1 Pt 2):293-8.
7. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998 May 12;97(18):1837-47.
8. D'Agostino RB, Russell MW, Huse DM, Ellison RC, Silbershatz H, Wilson PW, Hartz SC. Primary and subsequent coronary risk appraisal: new results from the Framingham study. Am Heart J. 2000 Feb;139(2 Pt 1):272-81.
9. D'Agostino RB Sr, Grundy S, Sullivan LM, Wilson P; CHD Risk Prediction Group. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA. 2001 Jul 11;286(2):180-7.
10. Conroy RM, Pyorala K, Fitzgerald AP, Sans S, Menotti A, De Backer G, De Bacquer D, Ducimetiere P, Jousilahti P, Keil U, Njolstad I, Oganov RG, Thomsen T, Tunstall-Pedoe H, Tverdal A, Wedel H, Whincup P, Wilhelmsen L, Graham IM; SCORE project group. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J. 2003 Jun;24(11):987-1003.
11. Thomsen TF, Davidsen M, Ibsen H, Jorgensen T, Jensen G, Borch-Johnsen K. A new method for CHD prediction and prevention based on regional risk scores and randomized clinical trials; PRECARD and the Copenhagen Risk Score. J Cardiovasc Risk. 2001 Oct;8(5):291-7.
12. Odell PM, Anderson KM, Kannel WB. New models for predicting cardiovascular events. J Clin Epidemiol. 1994 Jun;47(6):583-92.
13. Hosmer DW, Hosmer T, Le Cessie S, Lemeshow S. A comparison of goodness-of-fit tests for the logistic regression model. Stat Med. 1997 May 15;16(9):965-80.
14. Sheridan S, Pignone M, Mulrow C. Framingham-based tools to calculate the global risk of coronary heart disease: a systematic review of tools for clinicians. J Gen Intern Med. 2003 Dec;18(12):1039-52.
15. Menotti A, Puddu PE, Lanti M. Comparison of the Framingham risk function-based coronary chart with risk function from an Italian population study. Eur Heart J. 2000 Mar;21(5):365-70.
16. Ramachandran S, French JM, Vanderpump MP, Croft P, Neary RH. Using the Framingham model to predict heart disease in the United Kingdom: retrospective study. BMJ. 2000 Mar 11;320(7236):676-7.
17. Bastuji-Garin S, Deverly A, Moyse D, Castaigne A, Mancia G, de Leeuw PW, Ruilope LM, Rosenthal T, Chatellier G; Intervention as a Goal in Hypertension Treatment Study Group. The Framingham prediction rule is not valid in a European population of treated hypertensive patients. J Hypertens. 2002 Oct;20(10):1973-80.
18. Brindle P, Emberson J, Lampe F, Walker M, Whincup P, Fahey T, Ebrahim S. Predictive accuracy of the Framingham coronary risk score in British men: prospective cohort study. BMJ. 2003 Nov 29;327(7426):1267.
19. Hense HW, Schulte H, Lowel H, Assmann G, Keil U. Framingham risk function overestimates risk of coronary heart disease in men and women from Germany - results from the MONICA Augsburg and the PROCAM cohorts. Eur Heart J. 2003 May;24(10):937-45.
20. Boudik F, Reissigová J, Hrach K, Tomečová M, Bultas J, Anger Z, Aschermann M, Zvárová J. Primary prevention of coronary artery disease among middle aged men in Prague: twenty-year follow-up results. Atherosclerosis. (In press)
21. Wang Z, Hoy WE. Is the Framingham coronary heart disease absolute risk function applicable to Aboriginal people? Med J Aust. 2005 Jan 17;182(2):66-9.
22. Orford JL, Sesso HD, Stedman M, Gagnon D, Vokonas P, Gaziano JM. A comparison of the Framingham and European Society of Cardiology coronary heart disease risk prediction models in the normative aging study. Am Heart J. 2002 Jul;144(1):95-100.
23. Suka M, Sugimori H, Yoshida K. Validity of the Framingham risk model applied to Japanese men. Methods Inf Med. 2002;41(3):213-5.
24. Empana JP, Ducimetiere P, Arveiler D, Ferrieres J, Evans A, Ruidavets JB, Haas B, Yarnell J, Bingham A, Amouyel P, Dallongeville J; PRIME Study Group. Are the Framingham and PROCAM coronary heart disease risk functions applicable to different European populations? The PRIME Study. Eur Heart J. 2003 Nov;24(21):1903-11.
25. Marrugat J, D'Agostino R, Sullivan L, Elosua R, Wilson P, Ordovas J, Solanas P, Cordon F, Ramos R, Sala J, Masia R, Kannel WB. An adaptation of the Framingham coronary heart disease risk function to European Mediterranean areas. J Epidemiol Community Health. 2003 Aug;57(8):634-8.
26. Liu J, Hong Y, D'Agostino RB Sr, Wu Z, Wang W, Sun J, Wilson PW, Kannel WB, Zhao D. Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese Multi-Provincial Cohort Study. JAMA. 2004 Jun 2;291(21):2591-9.
27. Reissigová J, Tomečková M. Intervention of the risk factors of atherosclerosis and cardiovascular mortality. A 20-year primary prevention study from a statistician's point of view. Cor et Vasa. 2003;45(5):249-55. (In Czech)
28. Jones AF, Walker J, Jewkes C, Game FL, Bartlett WA, Marshall T, Bayly GR. Comparative accuracy of cardiovascular risk prediction methods in primary care patients. Heart. 2001 Jan;85(1):37-43.